dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· November 25, 2025

Drilling Programs Define New Zones as Gold Still Targets $5,000

View original at globenewswire.com
Drilling Programs Define New Zones as Gold Still Targets $5,000 Issued on behalf of Lake Victoria Gold Ltd. VANCOUVER, British Columbia, Nov…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Core hole LADD031 demonstrates that the BIF is still thick and well mineralized at 570m depth toward the projected northwest edge of Adumbi deposit

    80% confidence
  • Gold will reach $5,055 per ounce by late 2026 driven by sustained central bank accumulation

    80% confidence
  • Lake Victoria Gold is executing dual-track strategy: developing Imwelo toward first production within 12 months of construction while maintaining optionality through Barrick's fully funded exploration

    80% confidence
  • The Q3 results from Barrick highlight a systematic and technically strong approach to unlocking the Tembo geology

    80% confidence
  • Gold will reach $5,055 per ounce by late 2026 driven by sustained central bank accumulation

    80% confidence
  • The high-grade results exceeded expectations and demonstrate exceptional potential of flagship project which ranks as one of highest-grade undeveloped open pittable gold deposits in Canada

    80% confidence
  • Q3 2025 was highly successful with construction of Stage 3 Plant under budget, multiple financial records, and company is in strongest financial position in history

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Drilling Programs Define New Zones as Gold Still Targets $5,000: Source | Via News | fr.via.news